Home/ Supplements/ Nattokinase/ Natto NSK Mega

Natto NSK Mega

product on market Capsule Progressive Professional from Progressive Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Natto NSK Mega
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetable Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 100.0mg (70 products)

Other Ingredients

Rice Flour Hydroxypropyl Methylcellulose
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: One vegetable capsule twice daily, or more, as directed by a health care professional. Take with 8-10 ounces of water, with or without food.

Warnings & Precautions

Not to be used by pregnant or lactating women.

Tamper evident band around cap and seal on bottle. Do not use if either seal is broken or missing.

Keep out of the reach of children.

Contains: soy.

Formulation Notes

Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)

Nattokinase without Vitamin K2

Additional Information

Sold only for dispensing by a licensed health professional.

GMP Good Manufacturing Practice Certified GMP Compliant 21 CFR 111

Metadata

Product Details

UPC / SKU3 51821 00454 9
DSLD Entry Date2022-04-11
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID262111
Data Updated2026-04-11
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.